Ysios news
21.10.20
SparingVision Raises €44.5 Million and Appoints Stéphane Boissel as Chief Executive Officer
28.09.20
Galecto Raises $64 Million to Accelerate Development of Clinical Pipeline
portfolio news
29.10.20
SparingVision Strengthens Management Team
27.10.20
Kala Pharmaceuticals Announces FDA Approval of EYSUVIS™ for the Short-Term Treatment of the Signs and Symptoms of Dry Eye Disease
